Sollinda Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.86M | Buy |
15,423
+12,407
| +411% | +$2.3M | 0.75% | 17 |
|
|
2025
Q1 | $632K | Sell |
3,016
-115
| -4% | -$24.1K | 0.18% | 33 |
|
|
2024
Q4 | $556K | Buy |
3,131
+123
| +4% | +$21.9K | 0.15% | 33 |
|
|
2024
Q3 | $594K | Buy |
3,008
+49
| +2% | +$9.68K | 0.17% | 34 |
|
|
2024
Q2 | $508K | Buy |
2,959
+53
| +2% | +$9.09K | 0.15% | 36 |
|
|
2024
Q1 | $529K | Sell |
2,906
-1,431
| -33% | -$261K | 0.17% | 32 |
|
|
2023
Q4 | $672K | Buy |
+4,337
| New | +$672K | 0.19% | 30 |
|